Skip to main content
. 2015 Aug 17;33(28):3186–3192. doi: 10.1200/JCO.2015.61.1525

Table 3.

Cycle 1 Drug-Related Toxicities (possible, probable, or definite) in Patients With HGG by Category

Category No. of Events (%)
Toxicity Grade
Related SAE
1-2 3-4 5
All toxicities (n = 565) 512 (90.6) 52 (9.2) 1 (< 1) 33 (5.8)
Constitutional 89 (15.7) 8 (1.4) 8 (1.4)
Cardiovascular 22 (3.8) 1 (< 0.5) 1 (< 0.5)
GI 84 (14.8) 2 (< 0.5) 2 (< 0.5)
Respiratory 4 (< 1) 2 (< 0.5) 2 (< 0.5)
Metabolic 34 (6) 3 (< 0.5) 3 (< 0.5)
Dermatologic 35 (6) 6 (1) 6 (1)
Neurologic 35 (6) 5 (< 1) 5 (< 1)
Hematologic
    WBC 42 (7) 12 (2) 5 (< 1)
    Hemoglobin 73 (13) 1 (0.8)
    Platelets 61 (11) 12 (2)
    Others 29 (5) 1 (< 1) 1
Subcategories of all related neurologic toxicities during cycle 1
    Encephalopathy 4 0 0
    Headache 18 1 0
    Neuropathy 18 2 0
    Other 35 3 0
    Total 75 6 0

NOTE. Toxicities within each category are listed on a per-patient basis. The sum of neurologic subcategories is greater than listed under neurology category.

Abbreviations: HGG, high-grade glioma; SAE, serious adverse event.